Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4 at 1:30 p.m. EST at the New York Palace Hotel.
Help employers find you! Check out all the jobs and post your resume.
